Paul Contestable

573 total citations
10 papers, 155 citations indexed

About

Paul Contestable is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paul Contestable has authored 10 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paul Contestable's work include SARS-CoV-2 and COVID-19 Research (5 papers), Trypanosoma species research and implications (4 papers) and COVID-19 Clinical Research Studies (3 papers). Paul Contestable is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Trypanosoma species research and implications (4 papers) and COVID-19 Clinical Research Studies (3 papers). Paul Contestable collaborates with scholars based in United States, Brazil and Canada. Paul Contestable's co-authors include Michael P. Busch, Éster Cerdeira Sabino, Brian Custer, Sheila M. Keating, Fábio Fernandes, Ashley I. Beyer, Antônio Luiz Pinho Ribeiro, Edécio Cunha‐Neto, M.P. Busch and Stephen R. Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and Alzheimer s & Dementia.

In The Last Decade

Paul Contestable

9 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Contestable United States 5 122 80 30 27 27 10 155
Rosália Morais Tôrres Brazil 7 125 1.0× 105 1.3× 27 0.9× 8 0.3× 17 0.6× 19 156
Carmen Fuenmayor Venezuela 5 257 2.1× 153 1.9× 100 3.3× 9 0.3× 47 1.7× 8 272
Á. Moncayo Switzerland 4 232 1.9× 159 2.0× 30 1.0× 9 0.3× 60 2.2× 4 270
Aglaé Tardin Switzerland 4 99 0.8× 67 0.8× 6 0.2× 32 1.2× 24 0.9× 4 120
Fernando Parreño Spain 4 176 1.4× 267 3.3× 5 0.2× 14 0.5× 57 2.1× 5 292
Jordana Grazziela Alves Coelho-dos-Reis Brazil 7 60 0.5× 36 0.5× 3 0.1× 24 0.9× 19 0.7× 13 101
Nathália Zini Brazil 9 28 0.2× 105 1.3× 5 0.2× 81 3.0× 10 0.4× 16 156
Fabián Rojas‐Larios Mexico 6 38 0.3× 29 0.4× 3 0.1× 40 1.5× 25 0.9× 28 111
Deepak Kumar Deep India 5 144 1.2× 218 2.7× 2 0.1× 5 0.2× 46 1.7× 8 226
Alison Mbekeani United Kingdom 5 43 0.4× 60 0.8× 15 0.6× 18 0.7× 7 110

Countries citing papers authored by Paul Contestable

Since Specialization
Citations

This map shows the geographic impact of Paul Contestable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Contestable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Contestable more than expected).

Fields of papers citing papers by Paul Contestable

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Contestable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Contestable. The network helps show where Paul Contestable may publish in the future.

Co-authorship network of co-authors of Paul Contestable

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Contestable. A scholar is included among the top collaborators of Paul Contestable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Contestable. Paul Contestable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grebe, Eduard, Mars Stone, Bryan R. Spencer, et al.. (2025). Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting. Emerging infectious diseases. 31(5). 958–966. 1 indexed citations
3.
Grebe, Eduard, Mars Stone, Bryan R. Spencer, et al.. (2024). Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors. Emerging infectious diseases. 30(8). 1621–1630. 8 indexed citations
4.
Moreira, Carlos Henrique Valente, Ana Luiza Bierrenbach, César Augusto Taconeli, et al.. (2023). Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease. SHILAP Revista de lepidopterología. 2. 1235925–1235925. 2 indexed citations
6.
Meyer, Erin, Graham Simmons, Eduard Grebe, et al.. (2021). Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay. Transfusion. 61(4). 1160–1170. 12 indexed citations
7.
Keating, Sheila M., Fábio Fernandes, Edécio Cunha‐Neto, et al.. (2015). Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease. International Journal of Cardiology. 199. 451–459. 60 indexed citations
8.
Baburina, Irina, et al.. (2013). P1–161: Performance testing of a fully automated, Chemiluminescent, beta‐amyloid 42 assay. Alzheimer s & Dementia. 9(4S_Part_5). 2 indexed citations
9.
Gorlin, Jed B., Susan Rossmann, G. M. Robertson, et al.. (2007). Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion. 48(3). 531–540. 28 indexed citations
10.
Tobler, Leslie H., et al.. (2006). Evaluation of a new enzyme‐linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion. 47(1). 90–96. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026